tenk.fyi

Replimune Group, Inc.

REPLNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$313.9M

26.9% YoY

EPS

$-3.38

10.1% YoY

Cash

$209.0M

88.1% YoY

FY 2026 · As of 2026-03-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro